Latest news and press releases about Cosmos Health Inc. (COSM): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes.
Price
| Price | $0.27 |
| Market Cap | $15M |
| Exchange | NASDAQ |
| Country | GR |
Valuation Ratios
| Price / Book | 0.92 |
| EV / EBITDA | -2.27 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -103.91% |
| Return on Invested Capital | -40.39% |
| Return on Assets | -29.24% |
| Gross Margin | 12.10% |
| Operating Margin | -25.34% |
| Net Margin | -29.33% |
Related companies: CASI · CLSD · FEMY · IINN · LSTA · MTVA · NCNA
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of COSM: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks